Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (9)
2021
-
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
Acta Neuropathologica Communications, Vol. 9, Núm. 1
2018
-
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Biochemical Pharmacology, Vol. 157, pp. 67-84
2016
2014
-
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
Human Molecular Genetics, Vol. 23, Núm. 3, pp. 749-754
-
Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization
Journal of Immunology, Vol. 193, Núm. 10, pp. 5181-5189
2013
-
Analysis of the C9orf72 Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide
Human Mutation, Vol. 34, Núm. 1, pp. 79-82
2011
-
New serotonin 5-HT 1A receptor agonists with neuroprotective effect against ischemic cell damage
Journal of Medicinal Chemistry, Vol. 54, Núm. 23, pp. 7986-7999